Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-γ
Ferdinando Nicoletti(University of Catania), C Zanussi(University of Catania), L Mughini(University of Milan), Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Marisa Gariglio(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), M Lunetta(University of Catania), S Guzzardi(University of Catania), Santo Landolfo(University of Turin)
Cited by 63
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508